Myofibrillar Ca2+ sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
AIMS: We studied the relationship between myofilament Ca(2+) sensitivity and troponin I (TnI) phosphorylation by protein kinase A at serines 22/23 in human heart troponin isolated from donor hearts and from myectomy samples from patients with hypertrophic obstructive cardiomyopathy (HOCM). METHODS AND RESULTS: We used a quantitative in vitro motility assay. With donor heart troponin, Ca(2+) sensitivity is two- to three-fold higher when TnI is unphosphorylated. In the myectomy samples from patients with HOCM, the mean level of TnI phosphorylation was low: 0.38 ± 0.19 mol Pi/mol TnI compared with 1.60 ± 0.19 mol Pi/mol TnI in donor hearts, but no difference in myofilament Ca(2+) sensitivity was observed. Thus, troponin regulation of thin filament Ca(2+) sensitivity is abnormal in HOCM hearts. HOCM troponin (0.29 mol Pi/mol TnI) was treated with protein kinase A to increase the level of phosphorylation to 1.56 mol Pi/mol TnI. No difference in EC(50) was found in thin filaments containing high and low TnI phosphorylation levels. This indicates that Ca(2+) sensitivity is uncoupled from TnI phosphorylation in HOCM heart troponin. Coupling could be restored by replacing endogenous troponin T (TnT) with the recombinant TnT T3 isoform. No difference in Ca(2+) sensitivity was observed if TnI was exchanged into HOCM heart troponin or if TnT was exchanged into the highly phosphorylated donor heart troponin. Comparison of donor and HOCM heart troponin by mass spectrometry and with adduct-specific antibodies did not show any differences in TnT isoform expression, phosphorylation or any post-translational modifications. CONCLUSION: An abnormality in TnT is responsible for uncoupling myofibrillar Ca(2+) sensitivity from TnI phosphorylation in the septum of HOCM patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The decrease in cTnI phosphorylation at Ser22/23 observed in this study (Figs. 2 A, C, and E) is consistent with previous reports which investigated HCM (59, 61, 62).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [61]
In the citing paper
“However, despite a dramatic reduction in the phosphorylation of observed consistently for cTnI in HCM, the Ca2+ binding affinity of troponin was unchanged (61), suggesting a reduction in the ability of cTnI phosphorylation to regulate myofilament calcium sensitivity in HCM.”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [61]
In the citing paper
“These data suggest that cTnI phosphorylation is uncoupled from myofilament Ca2+ sensitivity in the HCM phenotype.”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [61]
In the citing paper
“Furthermore, manipulation of the cTnI phosphorylation did not alter thin filament Ca2+ sensitivity in human HCM myofibrils, unlike in the thin filaments of donor hearts where increased cTnI phosphorylation led to decreased Ca2+ sensitivity (61).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [61]
Citations
Cites
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,279
The Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Watkins, H., Ashrafian, H., & Redwood, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0902923 · Cited by 496
Self-citationElliott, P. M., Gimeno, J. R., Tomé, M. T., Shah, J., Ward, D., Thaman, R., Mogensen, J., & McKenna, W. J. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl041 · Cited by 427
Self-citationMyosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
Van Driest, S. L., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 424
[33] Assays for actin sliding movement over myosin-coated surfaces
Kron, S. J., Toyoshima, Y. Y., Uyeda, T. Q. P., & Spudich, J. A. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)96035-p · Cited by 402
Morrow, A. G., Reitz, B. A., Epstein, S. E., Henry, W. L., Conkle, D. M., Itscoitz, S. B., & Redwood, D. R. (1975) · Circulation · doi:10.1161/01.cir.52.1.88 · Cited by 395
Anderson, P. A., Malouf, N. N., Oakeley, A. E., Pagani, E. D., & Allen, P. D. (1991) · Circulation Research · doi:10.1161/01.res.69.5.1226 · Cited by 379
van Dijk, S. J., Dooijes, D., dos Remedios, C., Michels, M., Lamers, J. M. J., Winegrad, S., Schlossarek, S., Carrier, L., ten Cate, F. J., Stienen, G. J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.838672 · Cited by 329
Marston, S., Copeland, O., Jacques, A., Livesey, K., Tsang, V., McKenna, W. J., Jalilzadeh, S., Carballo, S., Redwood, C., & Watkins, H. (2009) · Circulation Research · doi:10.1161/circresaha.109.202440 · Cited by 238
Self-citation
Research works printed but not linked: 1
- Memo, 2011, Mutations in thin filament proteins that cause familial dilated cardiomyopathy uncouple troponin I phosphorylation from changes in myofibrillar Ca2+ sensitivity, Circulation, 124, A13162
Cited by
The physiological role of cardiac cytoskeleton and its alterations in heart failure
Sequeira, V., Nijenkamp, L. L. A. M., Regan, J. A., & van der Velden, J. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.07.011 · Cited by 193
Troponin structure and function: a view of recent progress
Marston, S. B., & Zamora, J. E. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09513-1 · Cited by 122
Self-citationCardiac Disorders and Pathophysiology of Sarcomeric Proteins
van der Velden, J., & Stienen, G. J. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00040.2017 · Cited by 120
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
Self-citationOBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency
Marston, S. B., Montgiraud, C., Munster, A. B., Copeland, O., Choi, O., dos Remedios, C. G., Messer, A. E., Ehler, E., & Knöll, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138568 · Cited by 91
Self-citation
Metadata
- Authors
- Bayliss, C. R., Jacques, A. M., Leung, M.-C., Ward, D. G., Redwood, C. S., Gallon, C. E., Copeland, O., McKenna, W. J., dos Remedios, C., Marston, S. B., & Messer, A. E.
- Affiliations
- Imperial College London (GB)
- University of Birmingham (GB)
- University of Oxford (GB)
- University of Exeter (GB)
- University College London (GB)
- Corresponding author
- Marston, Steven B.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-24
- Volume
- 97
- Issue
- 3
- Pages
- 500-508
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W1983547122
- Cited by
- 34
- References
- 49
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 3 · 2012: 1
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/010/25918, PG/08/077/25587, RG/11/20/29266)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- hypertrophic obstructive cardiomyopathy, troponin I phosphorylation, troponin T isoforms, protein kinase A, thin filament regulation, myectomy
- MeSH terms
- Adult, Biopsy, Calcium, Cardiomyopathy, Hypertrophic, Dose-Response Relationship, Drug, Humans, Male, Middle Aged, Myocardium, Myofibrils, Phosphorylation, Protein Processing, Post-Translational, Mass Spectrometry, Cyclic AMP-Dependent Protein Kinases, Troponin I, Troponin T, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Myofibrillar Ca2+ sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. https://app.cochat.ai/papers/10.1093/cvr/cvs322
- The paper
- Bayliss, C. R., Jacques, A. M., Leung, M.-C., Ward, D. G., Redwood, C. S., Gallon, C. E., Copeland, O., McKenna, W. J., dos Remedios, C., Marston, S. B., & Messer, A. E. (2013). Myofibrillar Ca2+ sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. Cardiovascular Research. https://doi.org/10.1093/cvr/cvs322
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.